| 000 | 01459 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517210004.0 | ||
| 264 | 0 | _c20181108 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1878-0334 | ||
| 024 | 7 |
_a10.1016/j.dsx.2018.03.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDabbaghmanesh, Mohammad Hossein | |
| 245 | 0 | 0 |
_aVitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. _h[electronic resource] |
| 260 |
_bDiabetes & metabolic syndrome _cJul 2018 |
||
| 300 |
_a513-517 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
| 650 | 0 | 4 |
_aVitamins _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDanafar, Farideh | |
| 700 | 1 | _aEshraghian, Ahad | |
| 700 | 1 | _aOmrani, Gholamhossein Ranjbar | |
| 773 | 0 |
_tDiabetes & metabolic syndrome _gvol. 12 _gno. 4 _gp. 513-517 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dsx.2018.03.006 _zAvailable from publisher's website |
| 999 |
_c28224807 _d28224807 |
||